Ohm: Is this new to be able to measure CCR5 and PD-L1 via a blood test? Or has that been the case for a while? Do they measure CCR5 Receptor Occupancy or some other metric? This looks to my uneducated eye like a major selling point to oncologists; to be able to monitor their patients for efficacy and progress via a simple blood test.
Ganesha